Benitec Biopharma Inc. (BNTC) stock
BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.54−0.50 (-5.53%)
Close on Nov 16, 2026Market cap $297.90MP/E –Yield –
Benitec Biopharma operating margin
Operating margin is operating income as a percentage of revenue.
Benitec Biopharma's operating margin for the twelve months ending Mar 31, 2024 was -307028.6%. For fiscal 2023 it was -25441.3%, against -24457.5% the year before. The highest annual figure on record is 21.2% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Jun 30, 2023 | -25441.3% | −983.8 |
| FY2022 | Jun 30, 2022 | -24457.5% | −1413.5 |
| FY2021 | Jun 30, 2021 | -23044.1% | −14925.4 |
| FY2020 | Jun 30, 2020 | -8118.6% | −8139.8 |
| FY2019 | Jun 30, 2019 | 21.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -65000.0% | −45660.0 |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -8038.9% | +184711.1 |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -40071.4% | +339228.6 |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -7208.3% | +318691.7 |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -19340.0% | −14449.1 |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -192750.0% | −185210.7 |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -379300.0% | −376558.4 |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -325900.0% | −322366.7 |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -4890.9% | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -7539.3% | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -2741.6% | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -3533.3% | – |
See a number that looks wrong?